Abstract

To improve the accuracy of optical biosensors, a sensor is often incorporated in close proximity to the sensor performing the detection function in order to compensate for common-mode error sources that result in a detected signal but are not a result of biochemical binding to the sensor surface. These error sources include thermal drift, the refractive index of the test sample, and nonspecific binding. Because photonic-crystal biosensors do not allow lateral propagation of light along their surface, spatial images of biochemical-binding density may be generated in which each individual pixel of the image represents an independent sensor. Using this capability, a small region of a photonic-crystal surface can effectively contain a large number of active and reference pixels when the immobilized ligand is applied to only a portion of the imaged region. In this paper, the use of a photonic-crystal optical biosensor assay protocol and data-analysis method that results in elimination of common-mode error sources from the detected signal is described. When applied to biosensors embedded within a standard 96-well microplate format, the new method enables the use of nanoliter-scale quantities of immobilized ligand reagent, is insensitive to immobilized ligand nonuniformity, and allows rapid analysis of many biochemical assays in parallel

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.